Tag Archives: Matthew Bouley

DR Horton (DHI) Receives a Buy from Barclays

In a report issued on March 15, Matthew Bouley from Barclays maintained a Buy rating on DR Horton (DHI – Research Report), with a price target of $41. The company’s shares opened today at $40.46. Bouley commented: “We had the

Barclays Maintains a Buy Rating on Masco Corp (MAS)

Barclays analyst Matthew Bouley maintained a Buy rating on Masco Corp (MAS – Research Report) on February 8 and set a price target of $39. The company’s shares closed on Friday at $35.90. According to TipRanks.com, Bouley ‘s ranking currently

Barclays Remains a Sell on Toll Brothers (TOL)

Barclays analyst Matthew Bouley maintained a Sell rating on Toll Brothers (TOL – Research Report) today and set a price target of $32. The company’s shares opened today at $33.48. According to TipRanks.com, Bouley ‘s ranking currently consits of no

Barclays Thinks DR Horton’s Stock is Going to Recover

In a report released yesterday, Matthew Bouley from Barclays maintained a Buy rating on DR Horton (DHI – Research Report), with a price target of $41. The company’s shares closed yesterday at $34.22, close to its 52-week low of $33.70.

Toll Brothers (TOL) Gets a Sell Rating from Barclays

Barclays analyst Matthew Bouley maintained a Sell rating on Toll Brothers (NYSE: TOL) yesterday and set a price target of $37. The company’s shares closed yesterday at $36.35, close to its 52-week low of $33.47. According to TipRanks.com, Bouley is